在非恶性肝病中的白蛋白-白素得分应该得到适当的验证
Andrea Pasta1, Francesco Calabrese1, Maria Corina Plaz Torres1
1Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS-Ospedale Policlinico San Martino, Genoa 16132, Italy.
World journal of gastroenterology
|December 22, 2023
概括
专 - 胆红素 (ALBI) 评分显示了预测肝硬化患者脱补偿的潜力. 需要进一步的研究来验证其在非恶性肝病中的使用,解决方法方面的问题.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
- 临床预后 临床预后
背景情况:
- 起初用于肝细胞癌的白蛋白-白素 (ALBI) 评分被探索用于补偿性肝硬化病的预后评估.
- 减补是影响肝硬化患者生存的关键事件.
- 评估脱补偿风险有助于改善患者的预后.
研究的目的:
- 批判性地评估利用ALBI评分预测肝硬化患者三年内脱补偿的研究.
- 检查ALBI得分在非恶性肝病中的预后效用.
- 确定方法方面的问题,并建议未来的研究方向.
主要方法:
- 对ALBI评分用于脱补偿预测现有研究的批判性评估.
- 对报告的脱补偿事件和患者特征的分析.
- 识别诊断方法和样本大小的局限性.
主要成果:
- 关于专门的放射性诊断提出的担忧,可能包括非肝硬化患者.
- 观察到的水出血的占主导地位与文献冲突,通常引用炎作为最初的事件.
- 高ALBI等级患者的小样本大小可能会限制得分的有效性.
结论:
- 当前研究的方法限制可能会影响ALBI得分对预测脱补偿的可靠性.
- 对于非恶性肝病,建议对动态ALBI得分变化的进一步调查.
- 需要进行前性研究,以加强ALBI评分在这种情况下的有效性.
相关概念视频
01:26Diseases of the Liver and Gallbladder
555
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
555
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
108
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
108